Literature DB >> 1911108

Course and long-term outcome of idiopathic IgA nephropathy in children.

T Linné1, U Berg, S O Bohman, L Sigström.   

Abstract

The long-term outcome of idiopathic IgA nephropathy (IgAN) in children was investigated with regard to clinical course and biopsy changes. All patients with biopsy-verified IgAN (diagnosed by kidney biopsy 1970-1985) at three children's clinics in Sweden were included in the study. Thirty-four (10 females, 24 males), out of a total of 72 patients, had a follow-up period of 8 years or more (10.7 +/- 1.9 years, range 8-14). After this duration of follow-up, urine abnormalities were found in 47% (group A), proteinuria in 35%, hypertension in 9%, and decreased glomerular filtration rate (GFR) in 3% of patients. However, 53% had no clinical signs of disease (group B). GFR depression at the time of clinical presentation of IgAN was more common in group A than in group B (P = 0.017). At the first renal biopsy, which was performed after the same duration of IgAN in both groups, focal segmental glomerular changes were more often found in group A (P = 0.017), while diffuse proliferative changes were more common in group B (P = 0.031). The course of the IgAN was thus often very protracted, with some children developing hypertension as well as decreased renal function. However, after a period of 8 years or more of follow-up half of the patients did not show any clinical signs of the disease, which may indicate low disease activity or, possibly, recovery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911108     DOI: 10.1007/bf01453658

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

1.  Repeat renal biopsy in children with IgA nephropathy.

Authors:  N Yoshikawa; K Iijima; S Matsuyama; J Suzuki; A Kameda; S Okada; H Nakamura
Journal:  Clin Nephrol       Date:  1990-04       Impact factor: 0.975

2.  IgA nephropathy in patients followed-up for at least ten years.

Authors:  A R Clarkson; A J Woodroffe; I Aarons
Journal:  Semin Nephrol       Date:  1987-12       Impact factor: 5.299

3.  Idiopathic recurrent macroscopic hematuria and mesangial IgA-IgG deposits in children (Berger's disease).

Authors:  M Levy; H Beaufils; M C Gubler; R Habib
Journal:  Clin Nephrol       Date:  1972 Mar-Apr       Impact factor: 0.975

Review 4.  IgA nephropathy: perspectives on pathogenesis and classification.

Authors:  S N Emancipator; G R Gallo; M E Lamm
Journal:  Clin Nephrol       Date:  1985-10       Impact factor: 0.975

5.  Active and chronic phases of Berger's disease (IgA nephropathy).

Authors:  J T Feltis; J Churg; K M Holley; H Feiner; G Gallo; A S Ackad
Journal:  Am J Kidney Dis       Date:  1984-03       Impact factor: 8.860

Review 6.  Mesangial IgA nephropathy.

Authors:  P Kincaid-Smith; K Nicholls
Journal:  Am J Kidney Dis       Date:  1983-09       Impact factor: 8.860

7.  Mesangial IgA nephropathy.

Authors:  P S Kincaid-Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

8.  Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy.

Authors:  M Praga; V Gutierrez-Millet; J J Navas; L M Ruilope; J M Morales; J M Alcazar; I Bello; J L Rodicio
Journal:  Kidney Int       Date:  1985-07       Impact factor: 10.612

9.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

10.  Renal functional changes in acute glomerulonephritis in children. A one-year follow-up.

Authors:  A Aperia; A Bergstrand; O Broberger; T Linné; J Wasserman
Journal:  Acta Paediatr Scand       Date:  1979-03
View more
  8 in total

1.  Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study.

Authors:  Jaana Ronkainen; Marja Ala-Houhala; Helena Autio-Harmainen; Timo Jahnukainen; Olli Koskimies; Jussi Merenmies; Jukka Mustonen; Timo Ormälä; Juha Turtinen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

2.  Alteration of lung diffusion capacity in IgA nephropathy.

Authors:  S Ravilly; M Chaussain; J L Iniguez; A Lenhert; G Kalifa; P Brun; P Niaudet; D Gendrel
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

3.  Prognostication in children with renal disease--with emphasis on IgA nephropathy.

Authors:  R J Hogg; R Browne
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

4.  Follow-up of renal function and urinary protein excretion in childhood IgA nephropathy.

Authors:  U B Berg; U C Widstam-Attorps
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

5.  Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group.

Authors:  R J Hogg; F G Silva; R J Wyatt; J S Reisch; J C Argyle; D A Savino
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

Review 6.  Pediatric IgA Nephropathy in Europe.

Authors:  Rosanna Coppo
Journal:  Kidney Dis (Basel)       Date:  2019-01-24

Review 7.  An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy.

Authors:  Ron Hogg
Journal:  Pediatr Nephrol       Date:  2021-05-13       Impact factor: 3.714

8.  Outcome results in children with IgA nephropathy: a single center experience.

Authors:  Ipek Kaplan Bulut; Sevgi Mir; Betul Sozeri; Mustafa Orhan Bulut; Sait Sen; Nida Dincel
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.